422 related articles for article (PubMed ID: 23782265)
21. The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases.
Gao Y; Zhao H; Wang P; Wang J; Zou L
Scand J Immunol; 2018 Dec; 88(6):e12727. PubMed ID: 30341772
[TBL] [Abstract][Full Text] [Related]
22. Signal transducer and activator of transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92.
Braunschweig A; Poehlmann TG; Busch S; Schleussner E; Markert UR
Am J Reprod Immunol; 2011 Oct; 66(4):329-35. PubMed ID: 21385272
[TBL] [Abstract][Full Text] [Related]
23. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
Serrano-Marco L; Rodríguez-Calvo R; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
[TBL] [Abstract][Full Text] [Related]
24. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
[TBL] [Abstract][Full Text] [Related]
25. SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.
Luckett-Chastain LR; Ihnat MA; Mickle-Kawar BM; Gallucci RM
J Interferon Cytokine Res; 2012 May; 32(5):207-15. PubMed ID: 22313262
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.
Vartoukian SR; Tilakaratne WM; Seoudi N; Bombardieri M; Bergmeier L; Tappuni AR; Fortune F
Clin Exp Immunol; 2014 Sep; 177(3):618-29. PubMed ID: 24827536
[TBL] [Abstract][Full Text] [Related]
27. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals.
da Silva CG; Studer P; Skroch M; Mahiou J; Minussi DC; Peterson CR; Wilson SW; Patel VI; Ma A; Csizmadia E; Ferran C
Hepatology; 2013 May; 57(5):2014-25. PubMed ID: 23238769
[TBL] [Abstract][Full Text] [Related]
28. Ohwia caudata extract relieves the IL-17A-induced inflammatory response of synoviocytes through modulation of SOCS3 and JAK2/STAT3 activation.
Lu CY; Kuo CH; Kuo WW; Hsieh DJ; Wang TF; Shih CY; Lin PY; Lin SZ; Ho TJ; Huang CY
Environ Toxicol; 2023 Aug; 38(8):1914-1924. PubMed ID: 37163279
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
30. The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)-α
Convery O; Gargan S; Kickham M; Schroder M; O'Farrelly C; Stevenson NJ
FASEB J; 2019 Aug; 33(8):8732-8744. PubMed ID: 31163989
[TBL] [Abstract][Full Text] [Related]
31. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons.
Miao T; Wu D; Zhang Y; Bo X; Subang MC; Wang P; Richardson PM
J Neurosci; 2006 Sep; 26(37):9512-9. PubMed ID: 16971535
[TBL] [Abstract][Full Text] [Related]
32. Expression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli.
Demirel I; Säve S; Kruse R; Persson K
APMIS; 2013 Feb; 121(2):158-67. PubMed ID: 23030674
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoids increase interleukin-6-dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor.
Dittrich A; Khouri C; Sackett SD; Ehlting C; Böhmer O; Albrecht U; Bode JG; Trautwein C; Schaper F
Hepatology; 2012 Jan; 55(1):256-66. PubMed ID: 21898505
[TBL] [Abstract][Full Text] [Related]
34. Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.
Gao Y; Cimica V; Reich NC
J Biol Chem; 2012 Jun; 287(25):20904-12. PubMed ID: 22547065
[TBL] [Abstract][Full Text] [Related]
35. IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain.
Zhang L; Badgwell DB; Bevers JJ; Schlessinger K; Murray PJ; Levy DE; Watowich SS
Mol Cell Biochem; 2006 Aug; 288(1-2):179-89. PubMed ID: 16718380
[TBL] [Abstract][Full Text] [Related]
36. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
Tang Q; Jiang J; Liu J
Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
[TBL] [Abstract][Full Text] [Related]
37. Interferon alpha antagonizes STAT3 and SOCS3 signaling triggered by hepatitis C virus.
Zhao LJ; He SF; Wang W; Ren H; Qi ZT
Cytokine; 2016 Apr; 80():48-55. PubMed ID: 26945996
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.
Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W
Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278
[TBL] [Abstract][Full Text] [Related]
39. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.
Pietrangelo A; Dierssen U; Valli L; Garuti C; Rump A; Corradini E; Ernst M; Klein C; Trautwein C
Gastroenterology; 2007 Jan; 132(1):294-300. PubMed ID: 17241879
[TBL] [Abstract][Full Text] [Related]
40. SHPS-1/SIRP1alpha contributes to interleukin-6 signalling.
Sobota RM; Müller PJ; Khouri C; Ullrich A; Poli V; Noguchi T; Heinrich PC; Schaper F
Cell Signal; 2008 Jul; 20(7):1385-91. PubMed ID: 18450421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
